Literature DB >> 11052947

Structure of murine CTLA-4 and its role in modulating T cell responsiveness.

D A Ostrov1, W Shi, J C Schwartz, S C Almo, S G Nathenson.   

Abstract

The effective regulation of T cell responses is dependent on opposing signals transmitted through two related cell-surface receptors, CD28 and cytotoxic T lymphocyte-associated antigen 4 (CTLA-4). Dimerization of CTLA-4 is required for the formation of high-avidity complexes with B7 ligands and for transmission of signals that attenuate T cell activation. We determined the crystal structure of the extracellular portion of CTLA-4 to 2.0 angstrom resolution. CTLA-4 belongs to the immunoglobulin superfamily and displays a strand topology similar to Valpha domains, with an unusual mode of dimerization that places the B7 binding sites distal to the dimerization interface. This organization allows each CTLA-4 dimer to bind two bivalent B7 molecules and suggests that a periodic arrangement of these components within the immunological synapse may contribute to the regulation of T cell responsiveness.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11052947     DOI: 10.1126/science.290.5492.816

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  45 in total

1.  Enhancement of gp120-specific immune responses by genetic vaccination with the human immunodeficiency virus type 1 envelope gene fused to the gene coding for soluble CTLA4.

Authors:  Bishnu P Nayak; Gangadhara Sailaja; Abdul M Jabbar
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

2.  Structural and functional studies of Igalphabeta and its assembly with the B cell antigen receptor.

Authors:  Sergei Radaev; Zhongcheng Zou; Pavel Tolar; Khanh Nguyen; AnhThao Nguyen; Peter D Krueger; Nicole Stutzman; Susan Pierce; Peter D Sun
Journal:  Structure       Date:  2010-08-11       Impact factor: 5.006

3.  Ancient evolutionary origin of diversified variable regions demonstrated by crystal structures of an immune-type receptor in amphioxus.

Authors:  José A Hernández Prada; Robert N Haire; Marc Allaire; Jean Jakoncic; Vivian Stojanoff; John P Cannon; Gary W Litman; David A Ostrov
Journal:  Nat Immunol       Date:  2006-06-25       Impact factor: 25.606

Review 4.  Sequence, structure, function, immunity: structural genomics of costimulation.

Authors:  Kausik Chattopadhyay; Eszter Lazar-Molnar; Qingrong Yan; Rotem Rubinstein; Chenyang Zhan; Vladimir Vigdorovich; Udupi A Ramagopal; Jeffrey Bonanno; Stanley G Nathenson; Steven C Almo
Journal:  Immunol Rev       Date:  2009-05       Impact factor: 12.988

5.  An engineered lipocalin specific for CTLA-4 reveals a combining site with structural and conformational features similar to antibodies.

Authors:  D Schönfeld; G Matschiner; L Chatwell; S Trentmann; H Gille; M Hülsmeyer; N Brown; P M Kaye; S Schlehuber; A M Hohlbaum; A Skerra
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-05       Impact factor: 11.205

6.  Association between co-inhibitory molecule gene tagging single nucleotide polymorphisms and the risk of colorectal cancer in Chinese.

Authors:  Jie Ge; Lin Zhu; Junde Zhou; Guangxiao Li; Ye Li; Shuying Li; Zhiwei Wu; Jiesheng Rong; Huiping Yuan; Yanhong Liu; Qiang Chi; Daxun Piao; Yashuang Zhao; Binbin Cui
Journal:  J Cancer Res Clin Oncol       Date:  2015-01-22       Impact factor: 4.553

Review 7.  B7 family molecules as regulators of the maternal immune system in pregnancy.

Authors:  Margaret G Petroff; Antoine Perchellet
Journal:  Am J Reprod Immunol       Date:  2010-04-08       Impact factor: 3.886

8.  Remapping the type I diabetes association of the CTLA4 locus.

Authors:  H-Q Qu; J P Bradfield; S F A Grant; H Hakonarson; C Polychronakos
Journal:  Genes Immun       Date:  2009-12       Impact factor: 2.676

Review 9.  CD28 Costimulation: From Mechanism to Therapy.

Authors:  Jonathan H Esensten; Ynes A Helou; Gaurav Chopra; Arthur Weiss; Jeffrey A Bluestone
Journal:  Immunity       Date:  2016-05-17       Impact factor: 31.745

Review 10.  Coinhibitory Pathways in the B7-CD28 Ligand-Receptor Family.

Authors:  Frank A Schildberg; Sarah R Klein; Gordon J Freeman; Arlene H Sharpe
Journal:  Immunity       Date:  2016-05-17       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.